VGX Pharmaceuticals, based in Blue Bell, PA, is a clinical stage biotechnology company focused on developing innovative next generation DNA medicines to combat HPV-related diseases, cancer, and infectious diseases. Their proprietary technology utilizes optimized plasmid design and delivery to teach the body to produce disease-fighting proteins, with a focus on driving progress through cutting-edge technology.
With a commitment to redefining success in treatment paradigms, VGX Pharmaceuticals harnesses the power of DNA medicine to offer ground-breaking potential advantages, aiming to transform patient care globally. Their experienced team is dedicated to advancing DNA medicine technology and developing innovative therapies with the promise of benefiting patients worldwide.
Generated from the website